Literature DB >> 18301855

The association of Parkinson's disease with bone mineral density and fracture in older women.

J L Schneider1, H A Fink, S K Ewing, K E Ensrud, S R Cummings.   

Abstract

UNLABELLED: Among community-dwelling older women, compared to those without Parkinson's disease (PD), women with PD have 7.3% lower BMD and an increased risk for hip fracture (HR = 2.6).
INTRODUCTION: Studies reporting an association of Parkinson's disease (PD) with low bone mineral density (BMD) and increased fracture risk often have been prone to selection bias, and have not accounted for potentially important explanatory variables, including recent weight loss. Further, little is known about the association between PD and non-hip fractures. Consequently, we investigated the independent association of PD with hip BMD and long-term fracture risk.
METHODS: Associations of self-reported PD with hip BMD and incident hip and non-spine, non-hip fracture were analyzed using linear regression and Cox proportional hazards, respectively. This prospective cohort study analyzed 8,105 older women with known PD status (n = 73 with PD) at four US clinical centers of the Study of Osteoporotic Fractures.
RESULTS: Compared to women without PD, age-adjusted mean total hip BMD was 7.3% lower in women with PD. Women with PD had a 2.6-fold higher age-adjusted risk for incident hip fracture. Parkinson's disease was not significantly associated with non-spine, non-hip fractures.
CONCLUSIONS: In age-adjusted models, women with PD had lower hip BMD and increased hip fracture risk, associations that were no longer significant after further weight and multivariate adjustment. Older women with PD should be considered for evaluation and treatment to reduce their fracture risk.

Entities:  

Mesh:

Year:  2008        PMID: 18301855     DOI: 10.1007/s00198-008-0583-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  13 in total

1.  Risk factors for hip fracture among elderly patients with Parkinson's disease.

Authors:  Y Sato; M Kaji; T Tsuru; K Oizumi
Journal:  J Neurol Sci       Date:  2001-01-01       Impact factor: 3.181

2.  How valid is the clinical diagnosis of Parkinson's disease in the community?

Authors:  A Schrag; Y Ben-Shlomo; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

3.  Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group.

Authors:  J A Grisso; J L Kelsey; B L Strom; G Y Chiu; G Maislin; L A O'Brien; S Hoffman; F Kaplan
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

4.  Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota.

Authors:  O Johnell; L J Melton; E J Atkinson; W M O'Fallon; L T Kurland
Journal:  Age Ageing       Date:  1992-01       Impact factor: 10.668

5.  The accuracy of self-report of fractures in elderly women: evidence from a prospective study.

Authors:  M C Nevitt; S R Cummings; W S Browner; D G Seeley; J A Cauley; T M Vogt; D M Black
Journal:  Am J Epidemiol       Date:  1992-03-01       Impact factor: 4.897

6.  Fracture rates in Parkinson's disease compared with age- and gender-matched controls: a retrospective cohort study.

Authors:  Richard W Genever; Thomas W Downes; Pippa Medcalf
Journal:  Age Ageing       Date:  2005-01       Impact factor: 10.668

7.  Femoral neck and intertrochanteric fractures have different risk factors: a prospective study.

Authors:  K M Fox; S R Cummings; E Williams; K Stone
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

8.  Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures.

Authors:  Brent C Taylor; Pamela J Schreiner; Katie L Stone; Howard A Fink; Steven R Cummings; Michael C Nevitt; Paula J Bowman; Kristine E Ensrud
Journal:  J Am Geriatr Soc       Date:  2004-09       Impact factor: 5.562

9.  Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; M C Nevitt; W S Browner; K Stone; K M Fox; K E Ensrud; J Cauley; D Black; T M Vogt
Journal:  N Engl J Med       Date:  1995-03-23       Impact factor: 91.245

10.  Reduced bone density of the hip in elderly patients with Parkinson's disease.

Authors:  H Taggart; V Crawford
Journal:  Age Ageing       Date:  1995-07       Impact factor: 10.668

View more
  29 in total

Review 1.  Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.

Authors:  J M Pavon; H E Whitson; M S Okun
Journal:  Maturitas       Date:  2010-02-01       Impact factor: 4.342

2.  Chlorpyrifos Exposure Induces Parkinsonian Symptoms and Associated Bone Loss in Adult Swiss Albino Mice.

Authors:  Shaheen Jafri Ali; Govindraj Ellur; Kalpana Patel; Kunal Sharan
Journal:  Neurotox Res       Date:  2019-07-31       Impact factor: 3.911

3.  Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genome-wide associations.

Authors:  Mayetri Gupta; Ching-Lung Cheung; Yi-Hsiang Hsu; Serkalem Demissie; L Adrienne Cupples; Douglas P Kiel; David Karasik
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

4.  Risk of fracture in patients with Parkinson's disease.

Authors:  S Pouwels; M T Bazelier; A de Boer; W E J Weber; C Neef; C Cooper; F de Vries
Journal:  Osteoporos Int       Date:  2013-02-22       Impact factor: 4.507

Review 5.  Musculoskeletal problems in Parkinson's disease.

Authors:  Young Eun Kim; Beom S Jeon
Journal:  J Neural Transm (Vienna)       Date:  2013-02-19       Impact factor: 3.575

6.  Bone mineral density and vitamin D status in Parkinson's disease patients.

Authors:  F van den Bos; A D Speelman; M van Nimwegen; Y T van der Schouw; F J G Backx; B R Bloem; M Munneke; H J J Verhaar
Journal:  J Neurol       Date:  2012-10-09       Impact factor: 4.849

7.  Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fractures.

Authors:  Marcie Harris-Hayes; Allison W Willis; Sandra E Klein; Sylvia Czuppon; Beth Crowner; Brad A Racette
Journal:  J Bone Joint Surg Am       Date:  2014-02-19       Impact factor: 5.284

Review 8.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

9.  Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk.

Authors:  B Abrahamsen; K Brixen
Journal:  Osteoporos Int       Date:  2008-08-09       Impact factor: 4.507

10.  Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis.

Authors:  F-E Cotté; P Fardellone; F Mercier; A-F Gaudin; C Roux
Journal:  Osteoporos Int       Date:  2009-05-21       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.